MedTrace Logo

Efficacy of a Virtual Care Clinic in the Management of Diabetes Mellitus

NCT02681185 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2023-09-21

No results posted yet for this study

Summary

The study's goal is to promote accessible and cost-effective diabetes care through electronic means. Underserved populations including rural areas do not have diabetes specialists. Previous study data has shown the effectiveness of Internet communication in lowering a patient's Hemoglobin A1C, a measure of blood sugars, closer to the target number. The investigators thus wish to test the effectiveness of diabetes care provided by virtual means, including virtual consultations, online monitoring of blood sugars, diabetes education via web-based videos, and support/advice provided through phone or email by an Endocrinologist. The goal is to test if virtual care is a viable means to extend care for diabetes to underserved populations.

Conditions

Interventions

OTHER

Virtual Care

Virtual Care consists of the following services and resources: 1. Have a virtual consult through online methods or telephone with one of the study endocrinologists 2. Be encouraged to report blood sugar readings every 2 weeks to their endocrinologist for regular follow-up and feedback via online methods 3. Be given access to a website with modules that attempt to replicate the information learned in a diabetes teaching clinic 4. Be given access to a certified diabetes educator through online methods or telephone. This will cover any other information that cannot be personalized on the teaching website, such as specific diet advice and social support.

OTHER

Standard of Care

Standard of care offered in the patient's community. May involve in-person education at a diabetes centre and consultation with a healthcare professional.

Sponsors & Collaborators

  • Endocrine Research Society

    lead OTHER

Principal Investigators

  • Adam White, MD · Clinical Associate Professor, UBC

  • Monika Pawlowska, MD · Clinical Assistant Professor, UBC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2023-07-04
Completion
2023-07-04

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02681185 on ClinicalTrials.gov